Top Markets
Coin of the day
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Clasificación en acciones #13241
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Precio por acción
$4.99
Capitalización bursátil
$508.03M
Cambio (1 día)
-2.48%
Cambio (1 año)
2.10%
País
TW
Comercio Ever Supreme Bio Technology Co., Ltd (6712)

Categoría

Historial de desdoblamientos de acciones de Ever Supreme Bio Technology Co., Ltd (6712)
La acción Ever Supreme Bio Technology Co., Ltd (símbolo: 6712) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 31, 2026.
Una acción 6712 comprada antes de Aug 31, 2026 equivaldría hoy a 0 acciones 6712.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH